semaglutide approved for obesity Live Updates on Semaglutide's Current and Future Uses FDA Approves Semaglutide for Pediatric

GLP-1 is the hormone targeted by Ozempic to reduce appetite and promote satiety

Semaglutide shows promise in reducing liver fat and improving metabolic markers in patients with fatty liver disease, particularly when combined with structured weight loss

It has been approved as a second line treatment option for better glycaemic control in type 2 diabetes and currently under scrutiny for anti-obesity purpose

Elena Veselova // Shutterstock Taking Wegovy (semaglutide) can be a powerful step towards achieving weight loss goals and improving overall health--especially when done in conjunction with lifestyle changes, such as following a healthy diet

Learn how semaglutide belly fat reduction works, why waist size often changes first, and how to maximize results safely with simple daily habits.

Classifying obesity as a chronic disease and emphasizing the cost-effectiveness of treating overweight and obesity can encourage insurers to cover more costs associated with these medications